Disclosures
Agenda
Introduction
The Cannabis Plant
CBD and the Endocannabinoid System
CBD Binding
CBD's Impact on THC's Psychoactive Effects
Effects on Non-Endocannabinoid Signaling Systems
Is CBD Psychoactive?
CBD Conversion to THC
Drug Interactions, CBD Pharmacology, and CBD Products
Metabolism
Drug: Drug Interactions
CBD and Warfarin
CBD and Methadone
CBD and Anti-epileptic Drugs
Initiating CBD Anti-epileptic Therapy
CBD and Hepatic Impairment
CBD and Fatty Foods
Discontinuing CBD Anti-epileptic Therapy
Adverse Effects of Oral CBD
Forms of CBD
Common Modes of Administration
Full Spectrum, Broad Spectrum, CBD Isolate & Whole Plant CBD
Topical CBD
MedWatch
Accuracy of CBD Labels
Clinical Applications of CBD Therapy
Treatment Resistant Epilepsy and CBD
Prescribing Epidiolex (CBD)
Notifying the DEA
Mechanism of Action of Epidiolex
Treatment Resistant Epilepsy and CBD with THC
National Approval of CBD Products
Autism Spectrum Disorder
Parkinson’s Disease
Cancer Treatment
Arthritis
Depression
Pretreatment with CBD
CBD Research
Human vs. Animal Studies
CBD in Clinical Care Quizzes - Quiz 3 of 4
Some patients want to try CBD
Are the Medical Claims Valid?
Quality Control
Crossing the Border
CBD in Clinical Care Quizzes - Quiz 4 of 4

CBD Conversion to THC

CBD Conversion to THC

As previously stated, CBD and THC have the same chemical formula and their structures are very similar. When CBD is consumed orally and metabolized, does it get converted to THC? Will individuals who consume large amounts of CBD experience a THC “high” because the CBD gets converted into THC?

Interestingly, at least two different in vitro studies used simulated gastric fluid and showed that there is some evidence that CBD can be converted to THC. However, the results of these in vitro studies may not be applicable to humans who consume CBD orally, because simulated gastric fluid does not provide the same exact physiological conditions that exist in a human stomach. (WHO 39, p 11)

When testing humans undergoing CBD treatment, spontaneous conversion of CBD to THC has not been demonstrated. As an example, in a 6 week study in which Huntington’s disease patients were given high doses of oral CBD (700mg/day), the average CBD plasma concentration range was 5.9-11.2 ng/ml, while no delta-9-THC was detected.(WHO 39, p 11) Also, a summary of other studies examining the effects of high dose CBD did not show that the patients experienced THC-like effects, and some studies actually showed that the patients experienced effects opposite to those of THC. (Grotenhermen) Furthermore, in a study in which 120 healthy human subjects were given an oral solution containing CBD 300 mg, THC was not detected in plasma after administration of the CBD, and the study participants did not exhibit the psychomimetic effects typical of THC. (Crippa)

References

  • World Health Organization (WHO) – Expert Committee on Drug Dependence Thirty-ninth Meeting Cannabidiol (CBD) Pre-Review Report Agenda Item 5.2 Geneva, 6-10 November 2017
  • Grotenhermen F, Russo E,  Zuardi AW. Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. in Cannabis and Cannabinoid Research. 2016;1(1):102–112; DOI: 10.1089/can.2015.0004. Cannabis and Cannabinoid Research. 2017; 2(1): 1-4.
  • Crippa JA, Zuardi AW, Hallak, JE, et al. Oral Cannabidiol does not convert to delta 8 or delta 9 THC in humans: a pharmacokinetic study in healthy subjects. Cannabis and Cannabinoid Research. Published Online: 4 Oct 2019; https://doi.org/10.1089/can.2019.0024 Accessed October 2020